Pharmacogenetic evidence that Cd36 is a key determinant of the metabolic effects of pioglitazone | Charles Explorer

Pharmacogenetic evidence that Cd36 is a key determinant of the metabolic effects of pioglitazone

Publication at First Faculty of Medicine |

2002

Abstract

Genetic, pharmacogenetic

People